BAMCO INC /NY/ 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:15 am Sale | 2023-02-14 | 13G | MaxCyte, Inc. MXCT | BAMCO INC /NY/ | 2,182,982 2.140% | -2,948,852 (-57.46%) | Filing |
| 2022-02-15 2:06 pm Purchase | 2022-02-14 | 13G | MaxCyte, Inc. MXCT | BAMCO INC /NY/ | 5,131,834 5.070% | 5,131,834 (New Position) | Filing |